A blocking peptide containing 18 amino acids near the amino terminus of human NALP12.
Points forts
Source
Synthetic
(Accession #: NP_653288) The NALP12 Blocking Peptide has been validated for the following applications: Antibody Competition.
Caractéristiques techniques
| Marque | Novus Biologicals |
|---|
| Réf. B-LABO | BL-RE-046087 |
|---|
| Réf. fabricant | 18247485 |
|---|
| Gene ID (Entrez) | 91662 |
|---|
| Espèces | Human |
|---|
| Contenu et stockage | Store at -20 C. Avoid freeze-thaw cycles. |
|---|
| Formule | PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin. |
|---|
| À utiliser avec (application) | This Peptide is Useful as a Blocking Peptide for NBP1-76293. For Further Blocking Peptide Related Protocol, Click Here . |
|---|
| Alias de gène | FCAS2, Monarch-1, NACHT, leucine rich repeat and PYD containing 12, NACHT, LRR and PYD domains-containing protein 12, NALP12LRR and PYD containing protein 12, NLR family, pyrin domain containing 12, nucleotide-binding oligomerization domain, leucine rich repeat and pyrin domaincontaining 12, PYPAF7Monarch1, PYRIN-containing APAF1-like protein 7, Regulated by nitric oxide, RNO2 |
|---|
| Symbole de gène(s) | NLRP12 |
|---|
| Type de produit | NALP12 |
|---|
| Quantité | 0.05 mg |
|---|
| État réglementaire | RUO - research use only |
|---|
| Source | Synthetic |
|---|
| Consigne | 18 amino acids near the amino terminus of human NALP12 |
|---|
Une question, une configuration particulière ?
Contactez-nous pour un devis.
